61. 1998 Medicine For The Public Lecture Series November 10. kidney cancer Understanding How Genes Impact Cancer. W. Marston Linehan. Dr.Linehan's research focuses on the molecular genetics of kidney cancer. http://www.cc.nih.gov/ccc/98mfp/mfp98index.html

Brain imaging The environment and health Medical ethics Hyperactivity ... Dental health These topics will be covered in the 1998 Medicine for the Public lecture series, sponsored by the NIH Clinical Center. The lectures, which are free and open to the public, are held at 7 p.m. on Tuesdays in the Clinical Center's Masur Auditorium, National Institutes of Health, 9000 Rockville Pike, Building 10, Bethesda, Maryland. Medicine for the Public, 1998 The Medicine for the Public lecture series, now in its 22nd year, features physician-scientists working at the forefront of medical research at the National Institutes of Health. The series helps people understand the latest developments in medicinenew therapies, diagnostic procedures, and research. The emphasis is on current topics and speakers who can relate to the lay public. For additional information on specific topics or speakers, please call (301) 496-2563. October 6 Imaging My Brain R. Nick Bryan, M.D., Ph.D.

62. Kidney Cancer - Renal Cell Carcinoma kidney cancer Renal Cell Carcinoma. What is kidney cancer (renal cell carcinoma)?Renal cancer carcinoma (RCC) is the most common type of kidney cancer. http://www.afud.org/conditions/kc.html

Kidney Cancer Renal Cell Carcinoma What is Kidney Cancer? New Types of Cancer Statistics on Renal Cell Carcinoma Risk Factors for Renal Cell Carcinoma ... New Forms of Treatment in Kidney Cancer and Kidney Cancer Research What is Kidney Cancer (renal cell carcinoma)? Renal cancer carcinoma (RCC) is the most common type of kidney cancer. The kidneys are two large organs that sit in the back part of the abdominal cavity. The kidney's main function is to filter the blood and clean the body of excess water, salt , and waste products. Normal kidney cells grow in an orderly fashion but cancer cells divide and grow out of control and can disrupt normal body tissues and function of the organ. When the cancer cells grow, they form a mass which is often called a tumor. Sometimes these cancer cells can spread in the blood and form new tumors elsewhere. These new cancerous deposits are called metastases . Fortunately, most tumors are found before they metastasize or spread. New Types of Cancer There are four main types of renal cell carcinoma: clear cell type granular cell type mixed granular and clear cell type , and spindle cell type . The majority of patients develop clear cell or mixed type. The granules in the mixed type are mitochondrial

63. March 13, 2003 Press Release Cleveland Clinic Begins Enrolling Patients in Genzyme Molecular Oncology'skidney cancer Clinical Trial. We have detected that your http://www.genzyme.com/corp/media/GZMO PR-031303.asp

We have detected that your browser does not have Javascript turned on. This site is optimized for Javascript. You may experience difficulties browsing certain parts of the site. Home Search Contact Us Genzyme Websites Choose your area of interest Patients Health Care Professionals Business Customers Corporate Structure Investors Media News ... History Cleveland Clinic Begins Enrolling Patients in Genzyme Molecular Oncology's Kidney Cancer Clinical Trial Date: March 13, 2003 The prestigious Cleveland Clinic is now enrolling patients in a Phase I/II clinical trial in kidney cancer conducted by Genzyme Molecular Oncology (Nasdaq: GZMO). Ronald Bukowski, M.D., of the Cleveland Clinic, is the lead investigator of the trial at this site. Genzyme Molecular Oncology, a division of Genzyme Corporation of Cambridge, MA, is the first commercial entity in the United States to pursue development of patient-specific cancer vaccines produced using this electrical fusion approach. The multi-center study is also underway in Boston at the Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute. It uses an innovative vaccine made from electrically combining the patient's own cancer cells with powerful, immune-stimulating cells to fight the devastating disease. Up to twenty patients with advanced kidney cancer are expected to be treated in the trial. The vaccine will be administered over the course of twelve weeks. Genzyme Molecular Oncology will assess the vaccine's safety, and seek to measure any clinical and immunologic responses in the patients.

64. November 6, 2002 Press Release Genzyme Molecular Oncology Begins kidney cancer Clinical Trial. Up to twenty patientswith advanced kidney cancer are expected to be treated in the trial. http://www.genzyme.com/corp/media/GZMO PR-110602.asp

We have detected that your browser does not have Javascript turned on. This site is optimized for Javascript. You may experience difficulties browsing certain parts of the site. Home Search Contact Us Genzyme Websites Choose your area of interest Patients Health Care Professionals Business Customers Corporate Structure Investors Media News ... History Genzyme Molecular Oncology Begins Kidney Cancer Clinical Trial Date: November 6, 2002 First Time Vaccine Approach Tested in the U.S. Genzyme Molecular Oncology (Nasdaq: GZMO) launched a new clinical trial in kidney cancer on November 6, 2002, that uses an innovative vaccine made from combining the patient's own cancer cells with powerful, immune-stimulating cells to fight the devastating disease. Genzyme Molecular Oncology, a division of Genzyme Corporation, is the first commercial entity in the United States to pursue development of patient-specific cancer vaccines produced using this electrical fusion approach. The Phase I/II kidney cancer trial is now enrolling patients in Boston at the Beth Israel Deaconess Medical Center. Enrollment also is expected to begin shortly at the Dana-Farber Cancer Institute. David Avigan, M.D., director of the bone marrow transplant program at the Beth Israel Deaconess Medical Center and assistant professor at Harvard Medical School, is the lead investigator of the trial and participated in pre-clinical evaluation of this fusion approach. Up to twenty patients with advanced kidney cancer are expected to be treated in the trial. The vaccine will be administered over the course of twelve weeks. Genzyme Molecular Oncology will assess the vaccine's safety, and seek to measure any clinical and immunologic responses in the patients.

65. 07/13/00 Committee On The Judiciary - Dixon Statement Submitted by the kidney cancer Association. July 13, 2000. kidney cancer is an uncureddisease. There are approximately 200,000 Americans who have kidney cancer. http://www.house.gov/judiciary/dixo0713.htm

Written Testimony for the House Subcommittee on Courts and Intellectual Property of the Committee on the Judiciary "Gene Patents and Other Genomic Inventions" Submitted by the Kidney Cancer Association July 13, 2000 Thank you for allowing me to talk to you today. I am Carl Dixon, the President and Executive Director of the Kidney Cancer Association ("KCA" or "Association") a voluntary, patient organization, which for over a decade has been dedicated to helping kidney cancer patients and their families deal with the physical, emotional and social impact of kidney cancer. I hold a JD from the University of Chicago's Law School and an MA from the Fletcher School. As the only national kidney cancer patient organization, directed by patients for patients, the Association realizes the importance of a national policy which encourages and rewards the development of gene and genomic inventions. Kidney cancer is an uncured disease. There are approximately 200,000 Americans who have kidney cancer. About 30,000 new cases are diagnosed each year. And each year about 12,000 Americans die from kidney cancer. The incidence of kidney cancer in the nation is increasing at an annual rate of about 3% . It is one of only three types of cancer with an increasing incidence. The average age of a kidney cancer patient at the time of diagnosis is 62.5 years. The KCA appreciates the opportunity to provide written and oral testimony to the House Subcommittee on Courts and Intellectual Property of the Committee of the Judiciary (the "Subcommittee"). The Association is available to assist the Subcommittee with needed information as it continues to review gene patent and other genomic inventions.

66. Kidney Cancer kidney cancer. What Is kidney cancer? kidney cancer is cancer that affects thekidney. As kidney cancer grows, it may invade organs near the kidney. http://www.mamashealth.com/cancer/kidcancer.asp

Mamashealth.com Home Cancer Pages Anal Cancer Breast Cancer Cancer Colon Cancer ... Health Stories Links Tell A Friend about MAMA! Email Mama Floral Gift for your Loved Ones Optimal Nutrition for Optimal Health Donate $$$ and help support Mamashealth.com Kidney Cancer What Is Kidney Cancer? Kidney cancer is cancer that affects the kidney. As kidney cancer grows, it may invade organs near the kidney. Some of the areas it affects are the liver , colon, and pancreas . Kidney cancer cells may also break away from the original tumor and spread (metastasize) to other parts of the body. When kidney cancer spreads, cancer cells may appear in the lymph nodes. What are the Symptoms? In the early stages of kidney cancer, there may be no obvious symptoms. As the disease progresses, some of the common symptoms are: Blood in the urine; A lump or mass in the kidney area; Fatigue; Loss of appetite; Weight loss; Recurrent fevers ; and A pain in the side that doesn't go away; and High blood pressure What causes Kidney Cancer?

67. The Health Library —Cancer kidney cancer. kidney cancer MEDLINEplus. kidney cancer (Renal Cell Carcinoma)ACS.kidney cancer Home Page NCI. Renal Cell Cancer (PDQ®) TreatmentNCI. http://healthlibrary.stanford.edu/resources/internet/bodysystems/cancer4.html

Diseases and Disorders Use these links to jump directly to your topic of interest: AIDS-Related Cancers Bone Cancers Brain Cancers Breast Cancers ... Urologic Cancers Cancer: Page 1 Page 2 Page 3 Page 5 ... Page 7 Urologic Cancers Bladder Cancer Bladder Cancer : MEDLINEplus Bladder Cancer:ACS Bladder Cancer Home Page: NCI Bladder Cancer News:Oncolink ... Daily Fluid Intake and the Risk of Bladder Cancer in Men: American Academy of Family Physicians Kidney Cancer, Adult Kidney Cancer: MEDLINEplus Kidney Cancer (Renal Cell Carcinoma):ACS Kidney Cancer Home Page: NCI Kidney Cancer News:Oncolink Kidney Cancer, Childhood Wilms' Tumor : MEDLINEplus Wilms' Tumor:ACS Wilms' Tumor News:Oncolink Ureteral and Urethral Cancer Urethral Cancer News:Oncolink Endocrine Cancers Adrenal Cancer Adrenal Cortical Cancer:ACS Adrenocortical Carcinoma Home Page:NCI Adrenal Cancer:EndocrineWeb.com Adrenal Cancer News:Oncolink Parathyroid Cancer Parathyroid Cancer:EndocrineWeb.com Parathyroid Cancer News:Oncolink Pituitary Cancer Pituitary Tumor:ACS Pituitary Cancer News:Oncolink Thymus Cancer Thymus Cancer:MEDLINEplus Thymus Cancer:ACS Thyroid Cancer Thyroid Cancer:MEDLINEplus Introduction to Thyroid Cancer:Oncolink Thyroid Cancer:ACS Thyroid Cancer Home Page:NCI ... Thyroid Cancer:EndocrineWeb.com

68. Kidney Cancer kidney cancer. Definition. kidney cancer is a disease in which the cells in certaintissues of the kidney start to grow uncontrollably and form tumors. http://www.healthatoz.com/healthatoz/Atoz/ency/kidney_cancer.html

Encyclopedia Index K Home Encyclopedia Encyclopedia Index K Kidney cancer Definition Kidney cancer is a disease in which the cells in certain tissues of the kidney start to grow uncontrollably and form tumors. Renal cell carcinoma, which occurs in the cells lining the kidneys (epithelial cells), is the most common type of kidney cancer. Eighty-five percent of all kidney tumors are renal cell carcinomas. Wilms' tumor is a rapidly developing cancer of the kidney most often found in children under four years of age. Description The kidneys are a pair of organs shaped like kidney beans that lie on either side of the spine just above the waist. Inside each kidney are tiny tubes (tubules) that filter and clean the blood, taking out the waste products and making urine. The urine that is made by the kidney passes through a tube called the ureter into the bladder. Urine is held in the bladder until it is discharged from the body. Renal cell carcinoma generally develops in the lining of the tubules that filter and clean the blood. Cancer that develops in the central portion of the kidney (where the urine is collected and drained into the ureters) is known as transitional cell cancer of the renal pelvis. Transitional cell cancer is similar to bladder cancer Kidney cancer accounts for 3% of all cancers. According to the American Cancer Society, approximately 30,000 new cases of kidney cancer will be found in 1998. Kidney cancer occurs most often in people between 50 and 60 years old. Men are twice as likely as women are to have cancer of the kidney. Other risk factors for the development of kidney cancer include Hispanic heritage, and pre-existing von Hippel-Lindau disease.

69. Sloan-Kettering - Kidney Cancer At Memorial SloanKettering Cancer Center, patients with kidney cancer receive themost effective treatment while preserving as much kidney function as possible http://www.mskcc.org/mskcc/html/362.cfm

var tab = tabs[tabs.length] = []; tab.id = 13; var TAB_WWWROOT = "/mskcc/"; var tabDarkColor = "#336699"; var tabMediumColor = "#99BBCC"; createHeaderImageCache(44,512,5626,1072,5664,638,8228); formatTabs(tabs); createNavigationImageCache(457,361,603,6207,474,1979,11984,600,518,539) Cancer Information Types of Cancer Kidney Cancer Kidney Cancer Select a Kidney Cancer Topic Primary kidney cancer, also called renal cancer, is a malignant tumor that originates in the kidney. There are two main types of primary kidney tumors renal-cortical tumors and transitional-cell tumors. Renal-cortical tumors include the most common type of primary kidney cancer and account for nearly 90 percent of all kidney tumors. Kidney cancer is most frequently diagnosed in people between the ages of 50 and 70. Kidney cancer rarely strikes children and young adults; the exception is a pediatric kidney cancer called Wilms' tumor. Metastatic, or secondary, kidney tumors have spread to a kidney from somewhere else in the body. These may include sarcomas, carcinomas, and lymphomas. Metastasis to the kidney presenting as an isolated kidney tumor is extremely rare. In this section you can find up-to-date information about kidney cancer, and learn about Memorial Sloan-Kettering's expertise in caring for patients with this disease.

70. KIDNEY CANCER kidney cancer. This page contains the following information about kidney cancer http://www.nypcancer.org/kidney.html

Advanced Search Anal Bladder Breast ... Stomach Additional types of cancer will be online soon... KIDNEY CANCER This page contains the following information about Kidney Cancer: Overview Causes and Risk Factors Early Detection and Screening Diagnosis ... Treatment NewYork-Presbyterian Hospital has one of the oldest and respected kidney programs in the area and has made tremendous strides in the diagnosis and treatment of kidney cancer. Research is ongoing to detect markers for kidney cancer, allowing earlier diagnosis of this disease. Physicians here are applying newer techniques for 3D reconstruction imaging of kidney tumors, which aid in planning for surgical treatment; are involved in the development of less toxic treatments for advanced kidney cancer using the patient's own immune system; are using cryotherapy to treat patients with kidney cancers; and leading the field in the role of nephron sparing (kidney sparing) surgery and laparoscopic kidney removal. Patients also have access to NewYork-Presbyterian Hospital's Center for Holistic Urology, which offers nutritional guidance, biofeedback and other complementary therapies. Overview The kidneys, two large bean shaped organs on either side of the spine below the rib cage, are responsible for filtering the blood and ridding the body of waste products in the urine. Urine leaves the kidneys through a long slender tube call a ureter. The ureters connect to the bladder, where urine is stored until it leaves the body. There are an estimated 30,000 new cases of kidney cancer each year in the United States - affecting adults and children (albeit rare), and men twice as frequently as women. The most common type of kidney cancer in adults is renal cell cancer, which accounts for about 85 percent of kidney tumors. Wilm’s tumor is the most common type of kidney cancer in children. (see Pediatric Cancer)

71. ABC7Chicago.com: Freeze Away Kidney Cancer Freeze Away kidney cancer. January 19, 2003 — A new approach totreating kidney cancer leaves patients with a chill of relief. http://abclocal.go.com/wls/health/011903_hs_kidney.html

Quick Links Extra Info News Weather Traffic Sports HealthBEAT Technology Entertainment Consumer News Strange News ABC7 Bios Recipes on ABC7 News Mr. Food Restaurant Reviews All About Kids Disability Issues Someone You Should Know ABC7 I-Team Get ABC7Now ABC7 ENews ABC Programs Primetime Soaps 190 North Message Boards About ABC7 Contact ABC7 F.A.Q Job Listings Contests ABC7 Online Store Community Events Area Guide 360 Chicago Movies ABC7 Legal Center ABC7 Health Center Freeze Away Kidney Cancer January 19, 2003 A new approach to treating kidney cancer leaves patients with a chill of relief. According to the National Kidney Cancer Foundation, there are more than 30,000 cases of kidney cancer diagnosed in the United States each year. It's typically treated by removing part or all of the kidney. Jennifer Matthews shows us how doctors are leaving the kidney in and taking the cancer out. Tom Johnson spends a lot of time caring for his pet pigeon. "I've had that particular pigeon, I guess, around 10 years. It's hard for them, but they learn to trust people, you know," said Tom Johnson, kidney cancer patient. He's talking about his pigeon, but Tom could be talking about himself. A kidney cancer diagnosis last year left him at the mercy of his doctors.

72. Cancercare - HHRD - Patient-to-Patient Network - Kidney Cancer Kidney Agency Name kidney cancer Association. Contact Phone 800850-9132. Fax847-332-2978. Website www.nkca.org. E-mail office@nkca.org. Program Type http://www.cancercare.org/hhrd/patient/kidney.asp

73. Kidney Cancer AREAS kidney cancer. Glossary. What is kidney cancer? kidney cancer is anabnormal, uncontrolled growth of cells in the kidney. According http://www.antigenics.com/diseases/kidneycancer.html

antigenics.com Print for Windows: CTRL-P Print for Mac: COMMAND-P DISEASE AREAS Kidney Cancer What is kidney cancer? Kidney cancer is an abnormal, uncontrolled growth of cells in the kidney . According to the American Cancer Society , the most common type is renal cell cancer (also called renal cell carcinoma ), which accounts for 85 percent of all kidney tumors. Renal cell cancer may develop in one or both kidneys. In the early stages, kidney cancer usually causes no obvious signs or symptoms. As kidney cancer grows, it may invade organs near the kidney such as the liver colon or pancreas . Kidney cancer cells may also break away from the original tumor and spread (or metastasize ) to other parts of the body such as the lymph nodes , bones or lungs, with about one third of cases showing metastasis at the time of diagnosis. How many people get kidney cancer? Renal cell cancer affects roughly three out of every 10,000 people. Each year, there are about 31,000 new cases in the United States, with more than 12,000 people dying from the disease. Overall, this cancer accounts for approximately 3 percent of tumors in adults. What causes kidney cancer?

74. Kidney Cancer Brochures CLINICAL TRIALS kidney cancer Brochure Request Form. Check the boxnext to the brochure(s) you are interested in receiving. Please http://www.antigenics.com/trials/brochures.html

CLINICAL TRIALS Kidney Cancer Brochure Request Form Check the box next to the brochure(s) you are interested in receiving. Note to physicians: If you are interested in placing a larger order of brochures for your renal cell carcinoma patients, please call us toll-free at Understanding Kidney Cancer A brochure for patients and their families explaining what kidney cancer is, how it is evaluated, and current treatments available. It also addresses your surgery and how you may feel afterwards. Tailoring a Vaccine: Research Studies With Oncophage For kidney cancer patients who may be interested in participating in a research study of Oncophage Antigenics values your privacy. All personal information provided here will be used only to fulfill your brochure request. For more information, Please let us know where you'd like to have the brochure(s) sent. Full Name: Address 1: Address 2: City: State/Province: Zip/Postal Code: Country: (if not U.S.) You may also download PDFs of these brochures from kidneycancervaccine.com The information provided on this site is intended to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Antigenics Clinical Trials Hotline Toll-free: 866-805-8993 E-mail: clinicalaffairs@antigenics.com

75. Disease Category Listing (33): Kidney Cancer Clinical Trials kidney cancer. Alaska. Anchorage; Research Site Antigenics,Inc. is enrolling approximately 650 patients for a clinical http://www.centerwatch.com/patient/studies/cat33.html

Clinical Trials: Kidney Cancer Alaska Anchorage; Research Site Arizona Tucson; Research Site California Duarte; City of Hope National Medical Center A Phase I Pharmacokinetic Study of STI-571 in Patients with Advanced Malignancies and Varying Degrees of Renal Dysfunction for the CTEP-sponsored Organ Dysfunction Working Group Duarte; City of Hope National Medical Center Compassionate Treatment of Malignant Pheochromocytoma with Radiation Los Angeles; Research Site Los Angeles; USC-Norris Comprehensive Cancer Center and Hospital Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma Los Angeles; UCLA Medical Center An open-label, multiple dose, dose-rising clinical trial of the safety of seven dose levels of ABX-EGF in Renal and Prostate Cancer, Pancreatic, Non-Small-Cell Lung, or Esophageal Cancer. San Francisco; Research Site Colorado Aurora; Research Site Connecticut Farmington; Research Site Florida Boca raton; Research Site Gainesville; Research Site Miami; Research Site Miami Shores; Innovative Medical Research of South Florida, Inc. Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma Tallahassee; Research Site

76. Kidney Cancer: Renal Cell Carcinoma (RCC) kidney cancer Renal Cell Carcinoma (RCC). It is further estimated thatover 11,000 deaths will result from this form of kidney cancer. http://www.urologyinstitute.com/html/kidney_cancer__renal_cell_carc.html

Rufus Green Jr., M.D., FACS, welcomes you to his offices on the campuses of RHD Memorial Medical Center, St. Paul Medical Center, and Medical Center of Las Colinas. Doctor Green brings a vast amount of experience to his specialty, as well as the belief that every patient is an "individual with unique needs." Featured Articles: Female Urology Erectile Dysfunction Erectile Dysfunction: Viagra ... Bladder Cancer Kidney Cancer: Renal Cell Carcinoma (RCC) The American Cancer Society estimates that approximately 28,000 new cases of renal cell carcinoma will be detected in 1998. It is further estimated that over 11,000 deaths will result from this form of kidney cancer. Neither chemotherapy nor radiation therapy have been shown to be effective against renal cell carcinoma that has spread beyond the kidney (metastatic). Thus, the early detection of these cancers, which are generally incurable except by surgical means, should translate into improvements in survival due to earlier operative intervention at a potentially curable stage. The cause of renal cell carcinoma is unknown, although tobacco and industrial carcinogens have been implicated. There is an association of renal cell carcinoma with several clinical syndromes such as Von Hippel Lindan Disease, Adult Polycystic Kidney Disease, and Acquired Renal Cystic Disease. Renal Cell Carcinoma has also been reported to run in certain families (a familial type).

77. Investigational Kidney Cancer Therapy Being Evaluated At UCSD January 8, 2001. INVESTIGATIONAL kidney cancer THERAPY BEING EVALUATEDAT UCSD. Advanced kidney cancer is usually fatal in less than a year. http://health.ucsd.edu/news/2001/01_08_BMT.html

January 8, 2001 INVESTIGATIONAL KIDNEY CANCER THERAPY BEING EVALUATED AT UCSD Physicians with the UCSD Blood and Marrow Transplant Program are evaluating an experimental type of stem cell transplant for its effectiveness against advanced kidney cancer, a disease known to be highly resistant to conventional therapy and usually fatal. This approach, called a nonmyeloablative allogeneic peripheral-blood stem-cell transplant, has shown promise in a small research study recently conducted at the National Institutes of Health (NIH). In that study of 19 patients, 53 percent had either complete or partial regression of their disease. Some patients have remained completely free of disease more than two years after treatment.* Advanced kidney cancer is usually fatal in less than a year. Fewer than 10 percent of people with kidney cancer survive for more than five years. Asad Bashey, M.D. Ph.D. “The NIH study was small, but the results were so dramatic we believe they represent a tremendous advance against this disease,” said the UCSD study’s principal investigator Asad Bashey, M.D., Ph.D., member of UCSD Cancer Center and assistant professor of medicine at UCSD School of Medicine. “These early results are particularly exciting when you consider that we’ve had precious little to offer patients who were not helped by conventional therapy.” The UCSD clinical trial is open to patients with a sibling who can donate stem cells for the transplant. The cells are collected from the bloodstream through a simple outpatient process known as pheresis. Patients receive relatively low doses of chemotherapy, followed by the transplant of donor cells. The process requires a three-to-four week hospitalization, and participants in the study will be followed on an outpatient basis for three years.

78. BestDoctors.com: Condition Summary: Kidney Cancer Articles by Dr. Sawczuk. kidney cancer. kidney cancer. What is kidney cancer? Kidneycancer is an abnormal growth of the cells lining the tubules of the kidney. http://www.bestdoctors.com/en/conditions/k/kidneycancer/kidneycancer_090900.htm

Site Map Language English Spanish Select A Language Search Condition Summaries Doctor Is In™ Ihor S. Sawczuk Articles by Dr. Sawczuk Kidney Cancer Kidney Cancer Ihor S. Sawczuk, MD Professor and Vice Chairman of Urology College of Physicians and Surgeons Columbia University What is a kidney? A kidney is a bean-shaped organ located toward the back of the body, beneath the rib cage. We have two kidneys, located on either side of our backbone. The primary function of the kidney is to act as a filter to cleanse the blood of waste products. The kidneys are composed of microscopic tubules that function as filtering units. As they filter the blood, the waste products accumulate in fluid, now called urine, which exits the kidneys via long tubes, the ureters, passing into the bladder where it is stored until it is expelled from the body. Figure 1. Diagram of a kidney

79. Science Today Transcript Number A. An Exciting New Treatment For kidney cancer. Figlin You can then vaccinatekidney cancer patients with a tumor lysate loaded dendritic cell. http://www.ucop.edu/sciencetoday/pages/archive/transcripts/1998/sci547.html

Program October 20, 1998 A. An Exciting New Treatment For Kidney Cancer B. Some Obstacles In Treating Osteonecrosis C. Scientific Serendipity D. Natural Attenuation And The Environment ... E. Breaking The Cycle Of Depression A. An Exciting New Treatment For Kidney Cancer Narrator: This is Science Today. A new immunotherapy treatment developed at the UCLA Jonsson Cancer Center dramatically increased life expectancy for some kidney cancer patients who would traditionally have about eight months to live. Dr. Robert Figlin says their approach stimulates a patient's immune system by manipulating their dendritic cells. Figlin: Dendritic cells are what are called antigen presenting cells. They are cells that exist within our body that basically interact with the immune system to prevent us from developing disease. Narrator: A patient's dendritic cells are loaded up with lysate, a product of their own an tumor. These cells are then given back to the patient.

80. External Links Cancer by Site Brain Cancer - Breast Cancer - Bone Cancer - Childhood Cancer -Cervical Cancer - Colon Cancer - Eye Cancer - kidney cancer - Leukemia - Lung http://www.uicc.org/links/

International Union Against Cancer Union Internationale Contre le Cancer Donate... Our Sponsors Who we are What we do ... Cancer Congress Oslo - June 2002 UICC WCCO World Conference for Cancer Organisations OECI Roll of Honour COPES Cancer Organizations, Public Education, and Patient Services National Cancer Control Planning GLOBALink The International Tobacco-Control Network Tobacco Control Nutrition Nursing Cancer Sites: Women Men Governing Bodies (Restricted) © 2002 UICC Access Terms Services Resource Materials Publications ... Press Releases Useful Links Contents Organisations related to UICC Research Biotechnology and Genome Clinical Trials ... Patient Support Cancer by Site: - Brain Cancer Breast Cancer Bone Cancer Childhood Cancer ... More Resources on the Internet Biotechnology and Genome Atlas of Genetics and Cytogenetics in Oncology and Haematology Cancer Genome Anatomy Project HumGen - University of Montreal National Center for Biotechnology Information Clinical Trials Cancer Trials at US National Cancer Institute Clinical trials at New England Medical Center (USA) European Organization for Research and Treatment of Cancer (EORTC) Medical Journals American Journal of Clinical Oncology-Cancer Clinical Trials Annals of Oncology Anti-Cancer Drug Design BMJ-British Medical Journal ... Biochimica et Biophysica Acta. Reviews on Cancer

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 106    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20